| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.6M | -83.7% |
| R&D Expense | $127.8M | +31.8% |
| SG&A Expense | $57.9M | +45.0% |
| Operating Income | -$184.1M | -44.8% |
| Interest Expense | $1.3M | +60.2% |
| Income Tax | $0 | — |
| Net Income | -$161.3M | -30.8% |
| EPS (Basic) | -$2.75 | +6.5% |
| EPS (Diluted) | -$2.75 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $63.2M | +87.7% |
| Short-term Investments | $431.0M | +44.9% |
| Accounts Receivable | $0 | -100.0% |
| Current Assets | $505.5M | +48.5% |
| Total Assets | $512.2M | +46.1% |
| Current Liabilities | $28.5M | +19.3% |
| Long-term Debt | $10.1M | +1.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$116.4M | -23.0% |
| Capital Expenditures | $921K | -47.7% |
| Investing Cash Flow | -$127.0M | +15.4% |
| Financing Cash Flow | $274.4M | +21.0% |
| Free Cash Flow | -$117.3M | -21.7% |
| +6.5% |
| Total Liabilities |
| $38.6M |
| +3.5% |
| Stockholders' Equity | $473.6M | +51.1% |